Literature DB >> 22643218

Telomere dysfunction puts the brakes on oncogene-induced cancers.

Cagatay Günes1, Karl Lenhard Rudolph.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22643218      PMCID： PMC3395100          DOI： 10.1038/emboj.2012.162

Source DB:  PubMed          Journal:  EMBO J        ISSN： 0261-4189            Impact factor:   11.598


× No keyword cloud information.
  12 in total

1.  Mitogen stimulation cooperates with telomere shortening to activate DNA damage responses and senescence signaling.

Authors:  A Satyanarayana; R A Greenberg; S Schaetzlein; J Buer; K Masutomi; W C Hahn; S Zimmermann; U Martens; M P Manns; K L Rudolph
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

2.  Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.

Authors:  Raffaella Di Micco; Marzia Fumagalli; Angelo Cicalese; Sara Piccinin; Patrizia Gasparini; Chiara Luise; Catherine Schurra; Massimiliano Garre'; Paolo Giovanni Nuciforo; Aaron Bensimon; Roberta Maestro; Pier Giuseppe Pelicci; Fabrizio d'Adda di Fagagna
Journal:  Nature       Date:  2006-11-30       Impact factor: 49.962

3.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

Review 4.  Senescence in tumours: evidence from mice and humans.

Authors:  Manuel Collado; Manuel Serrano
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

5.  Short telomeres limit tumor progression in vivo by inducing senescence.

Authors:  David M Feldser; Carol W Greider
Journal:  Cancer Cell       Date:  2007-04-12       Impact factor: 31.743

6.  Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.

Authors:  Jirina Bartkova; Nousin Rezaei; Michalis Liontos; Panagiotis Karakaidos; Dimitris Kletsas; Natalia Issaeva; Leandros-Vassilios F Vassiliou; Evangelos Kolettas; Katerina Niforou; Vassilis C Zoumpourlis; Munenori Takaoka; Hiroshi Nakagawa; Frederic Tort; Kasper Fugger; Fredrik Johansson; Maxwell Sehested; Claus L Andersen; Lars Dyrskjot; Torben Ørntoft; Jiri Lukas; Christos Kittas; Thomas Helleday; Thanos D Halazonetis; Jiri Bartek; Vassilis G Gorgoulis
Journal:  Nature       Date:  2006-11-30       Impact factor: 49.962

7.  Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes.

Authors:  E González-Suárez; E Samper; A Ramírez; J M Flores; J Martín-Caballero; J L Jorcano; M A Blasco
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

8.  Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication.

Authors:  Agnel Sfeir; Settapong T Kosiyatrakul; Dirk Hockemeyer; Sheila L MacRae; Jan Karlseder; Carl L Schildkraut; Titia de Lange
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

9.  Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study.

Authors:  P K Tsantoulis; A Kotsinas; P P Sfikakis; K Evangelou; M Sideridou; B Levy; L Mo; C Kittas; X-R Wu; A G Papavassiliou; V G Gorgoulis
Journal:  Oncogene       Date:  2007-12-17       Impact factor: 9.867

10.  Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence.

Authors:  Graeme Hewitt; Diana Jurk; Francisco D M Marques; Clara Correia-Melo; Timothy Hardy; Agata Gackowska; Rhys Anderson; Morgan Taschuk; Jelena Mann; João F Passos
Journal:  Nat Commun       Date:  2012-02-28       Impact factor: 14.919
View more
  5 in total

1.  A Comparative Assessment of Replication Stress Markers in the Context of Telomerase.

Authors:  Sabine Meessen; Gregoire Najjar; Anca Azoitei; Sebastian Iben; Christian Bolenz; Cagatay Günes
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

2.  Relative Telomere Length Change in Colorectal Carcinoma and Its Association with Tumor Characteristics, Gene Expression and Microsatellite Instability.

Authors:  Muhammad G Kibriya; Maruf Raza; Mohammed Kamal; Zahidul Haq; Rupash Paul; Andrew Mareczko; Brandon L Pierce; Habibul Ahsan; Farzana Jasmine
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.575

Review 3.  The emerging role of alternative splicing in senescence and aging.

Authors:  Mathieu Deschênes; Benoit Chabot
Journal:  Aging Cell       Date:  2017-07-13       Impact factor: 9.304

4.  A Novel Tissue and Stem Cell Specific TERF1 Splice Variant Is Downregulated in Tumour Cells.

Authors:  Yousef Ashraf Tawfik Morcos; Gregoire Najjar; Sabine Meessen; Britta Witt; Anca Azoitei; Mukesh Kumar; Gamal Wakileh; Klaus Schwarz; Hubert Schrezenmeier; Friedemann Zengerling; Christian Bolenz; Cagatay Günes
Journal:  Int J Mol Sci       Date:  2019-12-20       Impact factor: 5.923

Review 5.  Telomeres and Telomerase in the Development of Liver Cancer.

Authors:  Lena In der Stroth; Umesh Tharehalli; Cagatay Günes; André Lechel
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.